Hikal Limited (BOM: 524735)

Market Cap	45.96B
Revenue (ttm)	18.03B
Net Income (ttm)	678.00M
Shares Out	123.30M
EPS (ttm)	5.48
PE Ratio	68.01
Forward PE	38.28
Dividend	1.20 (0.32%)
Ex-Dividend Date	Sep 4, 2024

Volume	121,933
Open	379.45
Previous Close	376.85
Day's Range	370.80 - 383.05
52-Week Range	258.60 - 383.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Hikal

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, wh...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 2,061
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524735

Financial Performance

In 2023, Hikal's revenue was 17.85 billion, a decrease of -11.79% compared to the previous year's 20.23 billion. Earnings were 696.02 million, a decrease of -11.20%.